Treatment of neovascular age-related macular degeneration: insights into drug-switch real-world from the Berlin Macular Registry

PURPOSE: Bevacizumab, ranibizumab, and aflibercept are commonly used to treat neovascular age-related macular degeneration (nAMD). The results of various interventional, mostly randomized head-to-head studies, indicate statistical non-inferiority of these three drugs. The results of these studies ar...

Descripción completa

Detalles Bibliográficos
Autores principales: Riemer, Tommes, Berndt, Dominique, Böker, Alexander, Lehmann, Josefine, Schrifl, Ulrike, Rau, Saskia, Rübsam, Anne, Joussen, Antonia M., Zeitz, Oliver
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Medical Ophthalmology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10198863/
https://www.ncbi.nlm.nih.gov/pubmed/36633668
http://dx.doi.org/10.1007/s00417-022-05952-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10198863/
https://www.ncbi.nlm.nih.gov/pubmed/36633668
http://dx.doi.org/10.1007/s00417-022-05952-8

Ejemplares similares